Koji Yamaguchi
About
In The Last Decade
Koji Yamaguchi
453 papers receiving 11.5k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Surgery 6.5k
- Oncology 6.1k
- Pulmonary and Respiratory Medicine 2.9k
- Molecular Biology 2.2k
- Epidemiology 2.1k
Countries citing papers authored by Koji Yamaguchi
This map shows the geographic impact of Koji Yamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Yamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Yamaguchi more than expected).
Fields of papers citing papers by Koji Yamaguchi
This network shows the impact of papers produced by Koji Yamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Yamaguchi. The network helps show where Koji Yamaguchi may publish in the future.
Co-authorship network of co-authors of Koji Yamaguchi
This figure shows the co-authorship network connecting the top 25 collaborators of Koji Yamaguchi. A scholar is included among the top collaborators of Koji Yamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Yamaguchi. Koji Yamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 7 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 4 | |
| 10 | 3 | |
| 11 | 12 | |
| 12 | 5 | |
| 13 | 20 | |
| 14 | 6 | |
| 15 | 12 | |
| 16 | 11 | |
| 17 | OJ-084 The Effects of the Addition of Minimal Dose of Indapamide in Patients Receiving Angiotensin-II Receptor Blocker(Hypertension, clinical-3 (H) OJ14,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) | 1 |
| 18 | 26 | |
| 19 | The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3. | 25 |
| 20 | Papillary adenoma of the gallbladder associated with regurgitation of pancreatic juice through abnormally shaped union. Case report. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.